Review
doi: 10.1093/clinids/13.supplement_8.s691.
Pharmacology of bismuth-containing compounds
Affiliations
- PMID: 1925310
- DOI: 10.1093/clinids/13.supplement_8.s691
Item in Clipboard
Review
Pharmacology of bismuth-containing compounds
Rev Infect Dis.
1991 Jul-Aug.
Abstract
Bismuth compounds have been used for more than two centuries. A review of the modes of action, pharmacokinetics, and toxicity of two commonly used compounds, colloidal bismuth subcitrate and bismuth subsalicylate, is presented. In humans bismuth toxicity is unlikely when therapeutic doses of these compounds are administered for the appropriate duration. The recent use of bismuth compounds to eradicate infection with Helicobacter pylori and to prevent travelers' diarrhea has resulted in scientific reevaluation of these agents.
Similar articles
-
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.Can J Gastroenterol. 2000 Nov;14(10):885-9. doi: 10.1155/2000/709640. Can J Gastroenterol. 2000. PMID: 11111112
-
Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.Scand J Gastroenterol. 1994 Jun;29(6):528-31. doi: 10.3109/00365529409092467. Scand J Gastroenterol. 1994. PMID: 8079111
-
Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.Hepatogastroenterology. 1999 Sep-Oct;46(29):2882-6. Hepatogastroenterology. 1999. PMID: 10576366 Clinical Trial.
-
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.Ann Pharmacother. 1998 Jun;32(6):672-9. doi: 10.1345/aph.17247. Ann Pharmacother. 1998. PMID: 9640487 Review.
-
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002. Drugs. 1988. PMID: 3053124 Review.
Cited by
-
Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.Cancer Chemother Pharmacol. 1994;34(5):385-92. doi: 10.1007/BF00685562. Cancer Chemother Pharmacol. 1994. PMID: 7520843
-
The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.Adv Ther. 2021 May;38(5):2054-2076. doi: 10.1007/s12325-021-01676-z. Epub 2021 Mar 18. Adv Ther. 2021. PMID: 33738725 Free PMC article. Review.
-
Treatment of diarrheal disease.Paediatr Child Health. 2003 Sep;8(7):455-66. doi: 10.1093/pch/8.7.455. Paediatr Child Health. 2003. PMID: 20019955 Free PMC article. No abstract available.
-
Menstrual cycle perturbation by organohalogens and elements in the Cree of James Bay, Canada.Chemosphere. 2016 Apr;149:190-201. doi: 10.1016/j.chemosphere.2015.12.056. Epub 2016 Feb 6. Chemosphere. 2016. PMID: 26855224 Free PMC article.
-
Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Antimicrob Agents Chemother. 1995 Jan;39(1):66-9. doi: 10.1128/AAC.39.1.66. Antimicrob Agents Chemother. 1995. PMID: 7695331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical